$NMRA

Neumora Therapeutics, Inc.

Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Watertown, MA

NMRA chart

What traders are saying about $NMRA

Latest posts

Neumora Therapeutics, Inc. news

Neumora Therapeutics, Inc. key financials

USD2025202420232022
Net income$236.9M$243.8M-$235.9M-$130.9M
Diluted EPS$-1.45$-1.53$-3.63$-4.81
Total assets (year end)$191.0M$317.0M$496.2M$426.2M
Cash and equivalents (year end)$182.5M$142.1M$374.0M$240.9M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Neumora Therapeutics, Inc.

Ticker
NMRA (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Watertown, MA
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1885522

Frequently asked questions

What exchange is Neumora Therapeutics, Inc. listed on?

Neumora Therapeutics, Inc. trades on the Nasdaq under the ticker symbol NMRA.

What industry is Neumora Therapeutics, Inc. in?

Neumora Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.

Where is Neumora Therapeutics, Inc. headquartered?

Neumora Therapeutics, Inc.'s business address on file with the SEC is in Watertown, MA.

When does Neumora Therapeutics, Inc.'s fiscal year end?

Neumora Therapeutics, Inc.'s fiscal year ends on December 31.